Young blood transfusion: Difference between revisions
Violetriga (talk | contribs) legitimate claim |
Violetriga (talk | contribs) Totally fine to mention that numerous places reported it with hyperbole |
||
| Line 7: | Line 7: | ||
Ambrosia is a company that sells what it calls "young blood transfusions" for $8,000 under the guise of running a [[clinical trial]] to see if such transfusions lead to changes in the blood of recipients.<ref name=sbm/><ref name=Trends2017/> Jeff Bercovici wrote in ''[[Inc. (magazine)|Inc.]]'' that "life-extension science is a popular obsession" in [[Silicon Valley]] and that [[regenerative medicine]] was a fad which started in the 2000s. Bercovici states that there are rumours of wealthy technology bosses "spending tens of thousands of dollars for the procedures and young-person-blood". Technology entrepreneur [[Peter Thiel]], is a prominent investor in Ambrosia.<ref name="Inc">{{cite news|url=https://www.inc.com/jeff-bercovici/peter-thiel-young-blood.html|title=Peter Thiel Is Very, Very Interested In Young People's Blood|surname=Bercovici|first=Jeff|work=Inc|date=1 August 2016}}</ref><ref name="MIT17">{{cite news|url=https://www.technologyreview.com/s/603242/questionable-young-blood-transfusions-offered-in-us-as-anti-aging-remedy/|title=Questionable "Young Blood" Transfusions Offered in U.S. as Anti-Aging Remedy|publisher=MIT Technology Review |last=Maxmen |first=Amy |date=13 January 2017}}</ref> |
Ambrosia is a company that sells what it calls "young blood transfusions" for $8,000 under the guise of running a [[clinical trial]] to see if such transfusions lead to changes in the blood of recipients.<ref name=sbm/><ref name=Trends2017/> Jeff Bercovici wrote in ''[[Inc. (magazine)|Inc.]]'' that "life-extension science is a popular obsession" in [[Silicon Valley]] and that [[regenerative medicine]] was a fad which started in the 2000s. Bercovici states that there are rumours of wealthy technology bosses "spending tens of thousands of dollars for the procedures and young-person-blood". Technology entrepreneur [[Peter Thiel]], is a prominent investor in Ambrosia.<ref name="Inc">{{cite news|url=https://www.inc.com/jeff-bercovici/peter-thiel-young-blood.html|title=Peter Thiel Is Very, Very Interested In Young People's Blood|surname=Bercovici|first=Jeff|work=Inc|date=1 August 2016}}</ref><ref name="MIT17">{{cite news|url=https://www.technologyreview.com/s/603242/questionable-young-blood-transfusions-offered-in-us-as-anti-aging-remedy/|title=Questionable "Young Blood" Transfusions Offered in U.S. as Anti-Aging Remedy|publisher=MIT Technology Review |last=Maxmen |first=Amy |date=13 January 2017}}</ref> |
||
News media have widely reported such practices using [[hyperbole]], making hugely-exaggerated claims likening the procedure to the [[Fountain of Youth]] and the [[elixir of life]].<ref name="SA17" /><ref name="Med17" /> Others have related it to stories of [[vampire]]s.<ref name="Eco17" /><ref name="CBC18" /> |
|||
==References== |
==References== |
||
| Line 21: | Line 23: | ||
</ref> |
</ref> |
||
<ref name="SA17"> |
|||
{{cite news |
|||
|url=https://www.scientificamerican.com/article/fountain-of-youth-young-blood-infusions-ldquo-rejuvenate-rdquo-old-mice/ |
|||
|title=Fountain of Youth? Young Blood Infusions "Rejuvenate" Old Mice |
|||
|date=21 April 2017 |
|||
|surname=Makin |
|||
|first=Simon |
|||
|work=[[Scientific American]] |
|||
|accessdate=5 May 2018 |
|||
}} |
|||
</ref> |
|||
<ref name="CBC18"> |
|||
{{cite news |
|||
|url=http://www.cbc.ca/radio/quirks/march-3-2018-detecting-the-first-stars-young-blood-rejuvenation-acoustic-tractor-beam-more-1.4557129/the-vampire-molecule-scientists-discover-why-young-blood-helps-reverse-aging-1.4557132 |
|||
|title=The vampire molecule: scientists discover why young blood helps reverse aging |
|||
|publisher=[[CBC Radio]] |
|||
|date=3 March 2018 |
|||
|accessdate=6 May 2018 |
|||
}} |
|||
</ref> |
|||
<ref name="Med17"> |
|||
{{cite news |
|||
|url=https://medium.com/immortal-coin/young-blood-transfusions-the-elixir-of-youth-558de42d2086 |
|||
|title=Young Blood Transfusions - The Elixir Of Youth? |
|||
|publisher=Medium |
|||
|date=1 November 2017 |
|||
|accessdate=6 May 2018 |
|||
}} |
|||
</ref> |
|||
}} |
}} |
||
Revision as of 23:51, 22 May 2018
 | This article needs more reliable medical references for verification or relies too heavily on primary sources. (May 2018) |  |
Young blood transfusion refers to the transferal of blood taken from a young person into an older person with the intention of having a medicinal effect beyond that of a normal blood transfusion.[1]
There is no good evidence that "young blood" has any medicinal effect in people and all blood transfusions have risks, including blood-borne diseases.[1] As of of 2017 evidence from two large studies showed that transfusion of blood from younger donors was either no different from, or led to worse outcomes than, blood from older donors.[2] Research on blood transfusion outcomes has been complicated by the lack of careful characterization of the transfusion products that have been used in clinical trials; research had focused on how storage methods and duration might affect blood, but not on the differences among lots of blood themselves.[3]
Neuroscientist Tony Wyss-Coray leads a team of researchers at Stanford University investigating the use of young blood transfusions in mice. A study published by them in 2014 detailed the results of several tests including parabiosis in mice; as part of their investigations they sutured two mice of different ages together, with both animals sharing a circulatory system.[4] A company called Alkahest was spun out of the university's research in rodents; the company is collaborating with Grifols to create a blood plasma-based experimental biologic drug, which they propose to test in people with Alzheimer's.[5][6]
Ambrosia is a company that sells what it calls "young blood transfusions" for $8,000 under the guise of running a clinical trial to see if such transfusions lead to changes in the blood of recipients.[1][5] Jeff Bercovici wrote in Inc. that "life-extension science is a popular obsession" in Silicon Valley and that regenerative medicine was a fad which started in the 2000s. Bercovici states that there are rumours of wealthy technology bosses "spending tens of thousands of dollars for the procedures and young-person-blood". Technology entrepreneur Peter Thiel, is a prominent investor in Ambrosia.[7][8]
News media have widely reported such practices using hyperbole, making hugely-exaggerated claims likening the procedure to the Fountain of Youth and the elixir of life.[9][10] Others have related it to stories of vampires.[4][11]
References
- ^ a b c Novella, Steven (3 August 2016). "Parabiosis – The Next Snakeoil". Science-Based Medicine.
- ^ Garraud, O (August 2017). "Younger blood from older donors: Admitting ignorance and seeking stronger data and clinical trials?". Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 56 (4): 635–636. doi:10.1016/j.transci.2017.07.002. PMID 28780993.
- ^ Ning, S; Heddle, NM; Acker, JP (January 2018). "Exploring donor and product factors and their impact on red cell post-transfusion outcomes". Transfusion medicine reviews. 32 (1): 28–35. doi:10.1016/j.tmrv.2017.07.006. PMID 28988603.
- ^ a b "Can young blood really rejuvenate the old?". The Economist. 21 July 2017. Retrieved 6 May 2018.
- ^ a b de Magalhães, JP; Stevens, M; Thornton, D (November 2017). "The Business of Anti-Aging Science". Trends in biotechnology. 35 (11): 1062–1073. doi:10.1016/j.tibtech.2017.07.004. PMID 28778607.
- ^ Drew, L (27 September 2017). "Neuroscience: The power of plasma". Nature. 549 (7673): S26–S27. doi:10.1038/549S26a. PMID 28953857.
- ^ Bercovici, Jeff (1 August 2016). "Peter Thiel Is Very, Very Interested In Young People's Blood". Inc.
- ^ Maxmen, Amy (13 January 2017). "Questionable "Young Blood" Transfusions Offered in U.S. as Anti-Aging Remedy". MIT Technology Review.
- ^ Makin, Simon (21 April 2017). "Fountain of Youth? Young Blood Infusions "Rejuvenate" Old Mice". Scientific American. Retrieved 5 May 2018.
- ^ "Young Blood Transfusions - The Elixir Of Youth?". Medium. 1 November 2017. Retrieved 6 May 2018.
- ^ "The vampire molecule: scientists discover why young blood helps reverse aging". CBC Radio. 3 March 2018. Retrieved 6 May 2018.
